EJC Supplements

Published by: Pergamon-Elsevier Science Ltd  

People

  1. Motzer
    Motzer
  2. Solit
    Solit
  3. Hudis
    Hudis
  4. Rosen
    Rosen
  5. Fornier
    Fornier
  6. Scher
    Scher
  7. Aghajanian
    Aghajanian
  8. Blasberg
    Blasberg
  9. Fleisher
    Fleisher
  10. Hamlin
    Hamlin

Groups

  1. Department of Medicine (45)
  2. Solid Tumor Oncology Division (41)
  3. Genitourinary Oncology Service (19)
  4. Breast Medicine Service (17)
  5. GSK Faculty (14)
  6. Molecular Pharmacology and Chemistry Program Faculty (11)
  7. Sloan Kettering Institute Faculty (11)
  8. Survivorship Research (11)
  9. Human Oncology and Pathogenesis Program (9)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
Search Within
Formats
  1. Meeting Abstract (74)
  2. Journal Article (8)
Groups
  1. Department of Medicine (45)
  2. Solid Tumor Oncology Division (41)
  3. Genitourinary Oncology Service (19)
  4. Breast Medicine Service (17)
  5. GSK Faculty (14)
  6. Molecular Pharmacology and Chemistry Program Faculty (11)

More Groups

People
  1. Robert Motzer (9)
  2. David Solit (6)
  3. Clifford Hudis (5)
  4. Neal Rosen (5)
  5. Craig Moskowitz (3)
  6. Gnanamba Kondagunta (3)

More People

Years
  1. 2011 (1)
  2. 2010 (2)
  3. 2009 (4)
  4. 2008 (15)
  5. 2007 (22)
  6. 2006 (12)

More Years

Publishers
  1. Pergamon-Elsevier Science Ltd (82)

Results (82)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neratinib (HKI-272), an irreversible pan-ErbB receptor tyrosine kinase inhibitor: Preliminary results of a phase 2 trial in patients with advanced non-small cell lung cancer
    Meeting Abstract

    Besse, B.; Eaton, K. D.; Soria, J. C.; Lynch, T. J.; Miller, V.; Wong, K. K.; Powell, C; Quinn, S.; Zacharchuk, C.; Sequist, L. V.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • The concept of mathematically optimised dose-scheduling as applied to the adjuvant chemotherapy of primary breast cancer: Theory and recent results
    Journal Article

    Norton, L.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • Targeting MEK in tumors with BRAF and RAS mutations
    Meeting Abstract

    Solit, D.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Are size-based response criteria appropriate in the era of targeted therapy?
    Meeting Abstract

    Schwartz, L.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Phase 1/2 study of sunitinib in combination with gefitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Redman, B. G.; Hudes, G. R.; Kondagunta, G. V.; Patel, P. H.; Kim, S. T.; Chen, I.; Motzer, R. J.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Economic evaluation of sunitinib vs. interferon-alfa (IFN-alpha) in first-line metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Negrier, S.; Remak, E.; Brown, R.; Kim, S. T.; Charbonneau, C.; Motzer, R. J.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Sunitinib versus interferon (IFN)-alfa as first-line treatment of metastatic renal cell carcinoma (mRCC): Updated efficacy and safety results and further analysis of prognostic factors
    Meeting Abstract

    Motzer, R. J.; Michaelson, M. D.; Hutson, T. E.; Tomczak, P.; Bukowski, R. M.; Rixe, O.; Negrier, S.; Kim, S. T.; Chen, I.; Figlin, R. A.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Biomarkers of brain tumors to EGFR-TKI
    Meeting Abstract

    Mellinghoff, I.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Chemotherapy in elderly patients with renal insufficiency. Recommendations of the International Society of Geriatric Oncology (SIOG)
    Meeting Abstract

    Lichtman, S. M.; Wildiers, H.; Launay-Vacher, V.; Steer, C.; Chatelut, E.; Aapro, M.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology (SIOG) clinical practice recommendations
    Meeting Abstract

    Launay-Vacher, V.; Chatelut, E.; Lichtman, S. M.; Wildiers, H.; Steer, C.; Aapro, M.
    EJC Supplements (2007)

    Fulltext@MSK | Save

    • EJC Supplements – authorized name for:

    Name ISSN / ISBN Publisher
    EJC Supplements 1359-6349 Pergamon-Elsevier Science Ltd
    EJC Supplements 1359-6349 Unknown
    European Journal of Cancer Supplements 1359-6349 Elsevier Inc.
    European Journal of Cancer Supplements 1359-6349 Elsevier Inc.
    European Journal of Cancer Supplements 1359-6349 Pergamon-Elsevier Science Ltd
    European Journal of Cancer, Supplement 13596349 Elsevier Inc.
    European Journal of Cancer, Supplement 13596349 Unknown